Читать книгу De PhD y otros demonios - Sandra Bermeo - Страница 139

1. Lösch FA. Massenhafte Entwickelung von Amöben im Dickdarm. Virchow´s Archiv 1875; 65:196-211.

2. Pinilla AE, López MC, Viasus DF. Historia del protozoo Entamoeba histolytica. Rev Med Chile 2008; 136:118-24.

3. Cox FEG. The Wellcome Trust Illustrated History of Tropical Diseases. London: 1996. Am J Trop Med Hyg 1997; 56(1):116.

4. Pelletier J, Magendie F. Recherches chemies et physiologiques sur l´ipecacuanha. Ann Chimie Pysique 1817; 4 :172-85.

5. Faust EC. Some modern conceptions of amebiasis. Science. 1944 Jan 21;99(2560):45-51.

6. Boeck WC, Drbohlav J. The Cultivation of Endamoeba histolytica. Proc Natl Acad Sci U S A. 1925 May;11(5):235-8.

7. Diamond LS. Axenic cultivation of Entamoeba hitolytica. Science. 1961 Aug 4;134(3475):336-7.

8. Diamond LS, Clark CG. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol. 1993 May-Jun;40(3):340-4.

9. Sargeaunt PG, Jackson TF, Wiffen S, Bhojnani R, Williams JE, Felmingham D, et al. The reliability of Entamoeba histolytica zymodemes in clinical laboratory diagnosis. Arch Invest Med (Mex). 1987 Apr-Jun;18(2):69-75.

10. Reed SL. New concepts regarding the pathogenesis of amebiasis. Clin Infect Dis. 1995 Oct;21 Suppl 2:S182-5.

11. Haque R, Ali IK, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol. 1998 Feb;36(2):449-52.

12. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol. 2007 Mar;45(3):1035-7.

13. Bracha R, Mirelman D. Virulence of Entamoeba histolytica trophozoites. Effects of bacteria, microaerobic conditions, and metronidazole. J Exp Med. 1984 Aug 1;160(2):353-68.

14. Gomes MA, Melo MN, Pena GP, Silva EF. Virulence parameters in the characterization of strains of Entamoeba histolytica. Rev Inst Med Trop Sao Paulo. 1997 Mar-Apr;39(2):65-9.

15. Muñoz Mde L, Moreno MA, Pérez-Garcia JN, Tovar GR, Hernandez VI. Possible role of calmodulin in the secretion of Entamoeba histolytica electron-dense granules containing collagenase. Mol Microbiol. 1991 Jul;5(7):1707-14.

16. Pillai DR, Kain KC. Recent developments in amoebiasis:the Gal/GalNAc lectins of Entamoeba histolytica and Entamoeba dispar. Microbes Infect. 2000 Nov;2(14):1775-83.

17. Guerrant RL, Brush J, Ravdin JI, Sullivan JA, Mandell GL. Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils. J Infect Dis. 1981 Jan;143(1):83-93.

18. De León A. [Delayed prognosis in amebic hepatic abscess] [Artículo en español]. Arch Invest Med (Mex). 1970;1:Sup-pl:205-6.

19. Carrero JC, Cervantes-Rebolledo C, Aguilar-Díaz H, Díaz-Gallardo MY, Laclette JP, Morales-Montor J. The role of the secretory immune response in the infection by Entamoeba histolytica. Parasite Immunol. 2007 Jul;29(7):331-8.

20. Abd-Alla MD, Jackson TF, Rogers T, Reddy S, Ravdin JI. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response. Infect Immun. 2006 Jul;74(7):3897-903.

21. Pfaff AW, Kirch AK, Hoffmann WH, Banla M, Schulz-Key H, Geiger SM, et al. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles. Parasite Immunol. 2003 Jun;25(6):325-32.

22. Ravdin JI, Kelsall BL. Role of mucosal secretory immunity in the development of an amebiasis vaccine. Am J Trop Med Hyg. 1994;50(5 Suppl):36-41.

23. Stanley SL Jr. Progress towards an amebiasis vaccine. Parasitol Today. 1996 Jan;12(1):7-14.

24. Soong CJ, Kain KC, Abd-Alla M, Jackson TF, Ravdin JI. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis. 1995 Mar;171(3):645-51.

25. Aristizábal H, Acevedo J, Botero M. Fulminant amebic colitis. World J Surg. 1991 Mar-Apr;15(2):216-21.

26. Duque O. Fatal amebiasis in tropical América. Internat Pathol 1969; 10:9-14.

27. Duque O. Amebiasis fatal en Colombia. Antioquia Med 1968; 18:783-808.

28. Bravo C, Duque O. Ameboma. Presentación de 26 casos. Antioquia Med 1965; 15:39-52.

29. Lin CC, Kao KY. Ameboma: a colon carcinoma-like lesion in a colonoscopy finding. Case Rep Gastroenterol. 2013 Oct 9;7(3):438-41.

30. Villegas-Betanzo P, Martínez-Jiménez MA, Guevara-Torres L, Quintero-Meza K, Sánchez-Aguilar M, Arriaga-Caballero JE. Ameboma: possible therapeutic decisions in an amebiasis-endemic region. Gastroenterol Hepatol. 2015 Jan;38(1):7-11.

31. Fonte-Galindo L, Sánchez-Valdés L, Fernández-Ferrer MA, Marín-Iglesia H, Montano-Goodridge I, Nuñez-Fernández FA. Sobrediagnóstico microscópico de amebiasis intestinal: evaluación de una intervención en la provincia de Cienfuegos. Rev Cuba Invest Biomed 2003;22(3):173-9.

32. Chacín-Bonilla L. An update on amebiasis. Rev Med Chil. 2013 May;141(5):609-15.

33. Otan E, Akbulut S, Kayaalp C. Amebic acute appendicitis: systematic review of 174 cases. World J Surg. 2013 Sep;37(9):2061-73.

34. Ito D, Hata S, Seiichiro S, Kobayashi K, Teruya M, Kaminishi M. Amebiasis presenting as acute appendicitis: Report of a case and review of Japanese literature. Int J Surg Case Rep. 2014;5(12):1054-7.

35. Bernal-Parra C, Zapata-Muñoz CT, Durango- Galván HE, Álvarez-Ruiz CM. Agentes etiológicos de diarrea en niños atendidos en la Unidad de Capacitación para el tratamiento de la diarrea del Hospital Universitario San Vicente de Paúl de Medellín. Infect 2002; 6(4):204-11.

36. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers’ diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009 Apr;80(4):609-14.

37. González-Ruiz A, Haque R, Aguirre A, Castañón G, Hall A, Guhl F, et al. Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica. J Clin Pathol. 1994 Mar;47(3):236-9.

38. Petri WA Jr, Singh U. Diagnosis and management of amebiasis. Clin Infect Dis. 1999 Nov;29(5):1117-25.

39. Visser LG, Verweij JJ, Van Esbroeck M, Edeling WM, Clerinx J, Polderman AM. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non-endemic setting. Int J Med Microbiol. 2006 Oct;296(6):397-403.

40. Mirelman D, Nuchamowitz Y, Stolarsky T. Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar. J Clin Microbiol. 1997 Sep;35(9):2405-7.

41. Guzmán C, López MC, Reyes P, Gómez JE, Corredor A, Agudelo C. Diferenciación de Entamoeba histolytica y Entamoeba dispar en muestras de materia fecal por detección de adhesina de E. histolytica mediante ELISA. Biomé- dica 2001; 21:167-71.

42. Haque R, Roy S, Siddique A, Mondal U, Rahman SM, Mondal D, et al. Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg. 2007 Apr;76(4):713-7.

43. Stark D, van Hal SJ, Matthews G, Harkness J, Marriott D. Invasive amebiasis in men who have sex with men, Australia. Emerg Infect Dis. 2008 Jul;14(7):1141-3.

44. 44. Haque R, Mondal D, Kirkpatrick BD, Akther S, Farr BM, Sack RB, et al. Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh. Am J Trop Med Hyg. 2003 Oct;69(4):398-405.

45. Pinheiro SM, Carneiro RM, Aca IS, Irmão JI, Morais MA Jr, Coimbra MR, et al. Determination of the prevalence of Entamoeba histolytica and E. dispar in the pernambuco state of northeastern Brazil by a polymerase chain reaction. Am J Trop Med Hyg. 2004 Feb;70(2):221-4.

46. Chacín-Bonilla L. Amebiasis: aspectos clínicos, terapéuticos y de diagnóstico de la infección. Rev Med Chile 2013;141:609-15.

47. Gatti S, Swierczynski G, Robinson F, Anselmi M, Corrales J, Moreira J, et al. Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. Am J Trop Med Hyg. 2002 Jul;67(1):123-7.

48. Corredor A, Arciniegas E, Hernández CA. Parasitosis intestinal. Instituto Nacional de Salud, Bogotá, 2000.

49. Gallego ML, Gómez JE, Torres E, Lora F. Prevalencia de Entamoeba histolytica en asentamientos temporales post-terremoto de la ciudad de Armenia. Infectio 2003; 7(4):190-4.

50. Samie A, Barrett LJ, Bessong PO, Ramalivhana JN, Mavhandu LG, Njayou M, et al. Seroprevalence of Entamoeba histolytica in the context of HIV and AIDS: the case of Vhembe district, in South Africa’s Limpopo province. Ann Trop Med Parasitol. 2010 Jan;104(1):55-63.

51. Abdollahi A, Saffar H, Saffar H, Sheikhbahaei S, Rasoulinejad M. Is the evaluation of Entamoeba histolytica infection in HIV-positive patients of any clinical significance? Acta Med Iran. 2015;53(1):46-50.

52. Atías A, Sapunar J. Parodi V, Pérez C, Gabor M, Stagno S, et al. Tratamiento de la amebiasis intestinal crónica con Teclozán. Bol Chil Parasitol 1972; 27(3):119-21.

53. Zuluaga H, Botero D, Vélez H, Castaño A. Estudios terapéuticos y quimioprofilácticos con la droga antiamibiana Win-13.146. Antioquia Med 1971; 21:559-74.

54. Johnson PJ. Metronidazole and drug resistance. Parasitol Today. 1993 May;9(5):183-6.

55. Spillmann R, Ayala SC, Sanchez CE. Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers. Am J Trop Med Hyg. 1976 Jul;25(4):549-51.

56. Kauser H, Qadir M, Anwar W. Ocular side effect of tinidazole: a rare case report. J Family Med Prim Care. 2014 Oct-Dec;3(4):467-9.

57. Botero D. An overview of the clinical experience of secnidazole in giardiasis and amoebiasis. Drug Invest 1994; 8 (Suppl 1):47-52.

58. Restrepo M, Díaz T, Cuervo C. Valoración de la eficacia y tolerancia del Secnidazol a dosis única en niños con Amebiasis Intestinal Sintomática. Medicina UPB 1996; 15:59-65.

59. Fonte-Galindo L, Fernández-Ferrer M de L, Sánchez-Valdés L, Marín-Iglesias H, Montano-Goodridge I, Maestre-Mesa J. Eficacia antiamebiana del metronidazol demostrada en un estudio realizado en la provincia de Cienfuegos. Rev Cubana Med Trop 2002; 54:101-5.

60. Belkind-Valdovinos U, Belkind-Gerson J, Sánchez.Francia D, Espinoza-Ruiz MM, Lazcano-Ponce L. Evaluación de la nitazoxanida en dosis única y por tres días en parasitosis intestinal. Salud Publ México 2004;46(3):333-40.

61. Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007 Oct;101(10):1025-31.

62. Windsor JJ, Macfarlane L. Irritable bowel syndrome: the need to exclude Dientamoeba fragilis. Am J Trop Med Hyg. 2005 May;72(5):501.

63. Stensvold CR, Arendrup MC, Mølbak K, Nielsen HV. The prevalence of Dientamoeba fragilis in patients with suspected enteroparasitic disease in a metropolitan area in Denmark. Clin Microbiol Infect. 2007 Aug;13(8):839-42.

64. Nagata N, Marriott D, Harkness J, Ellis JT, Stark D. Current treatment options for Dientamoeba fragilis infections. Int J Parasitol Drugs Drug Resist. 2012 Sep 3;2:204-15.

65. De Jong MJ, Korterink JJ, Benninga MA, Hilbink M, Widdershoven J, Deckers-Kocken JM. Dientamoeba fragilis and chronic abdominal pain in children: a case-control study. Arch Dis Child. 2014 Dec;99(12):1109-13.

66. Cacciò SM, Sannella AR, Manuali E, Tosini F, Sensi M, Crotti D, et al. Pigs as natural hosts of Dientamoeba fragilis genotypes found in humans. Emerg Infect Dis. 2012 May;18(5):838-41.

67. Tshalaia LE. On a species of Entamoeba detected in sewage effluents. Med Parazit (Moscow) 1941;10:244-52.

68. Dreyer DA. Growth of a strain of Entamoeba histolytica at room temperature. Tex Rep Biol Med. 1961;19:393-6.

69. Clark CG, Diamond LS. The Laredo strain and other ‘Entamoeba histolytica-like’ amoebae are Entamoeba moshkovskii. Mol Biochem Parasitol. 1991 May;46(1):11-8.

70. Haque R, Faruque AS, Hahn P, Lyerly DM, Petri WA Jr. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infect Dis. 1997 Mar;175(3):734-6.

71. Ali IK, Hossain MB, Roy S, Ayeh-Kumi PF, Petri WA Jr, Haque R, et al. Entamoeba moshkovskii infections in children, Bangladesh. Emerg Infect Dis. 2003 May;9(5):580-4.

72. Zebardast N, Haghighi A, Yeganeh F, Seyyed Tabaei SJ, Gharavi MJ, Fallahi S, et al. Application of Multiplex PCR for Detection and differentiation of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii. Iran J Parasitol. 2014 Oct-Dec;9(4):466-73.

73. Burrows RB. Morphological differentiation of Entamoeba hartmanni and E. polecki from E. histolytica. Am J Trop Med Hyg. 1959 Sep;8:583-9.

74. Desowitz RS, Barnish G. Entamoeba polecki and other intestinal protozoa in Papua New Guinea Highland children. Ann Trop Med Parasitol. 1986 Aug;80(4):399-402.

75. Chacín-Bonilla L. Entamoeba polecki: human infections in Venezuela. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):634.

76. Santos HL, Bandyopadhyay K, Bandea R, Peralta RH, Peralta JM, Da Silva AJ. LUMINEX^®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools. Parasit Vectors. 2013 Mar 15;6:69.

77. Royer TL, Gilchrist C, Kabir M, Arju T, Ralston KS, Haque R, et al. Entamoeba bangladeshi nov. sp., Bangladesh. Emerg Infect Dis. 2012 Sep;18(9):1543-5.

78. Gilchrist CA. Entamoeba bangladeshi: An insight. Trop Parasitol. 2014 Jul;4(2):96-8.

79. Misra SP, Misra V, Dwivedi M. Ileocecal masses in patients with amebic liver abscess: etiology and management. World J Gastroenterol. 2006 Mar 28;12(12):1933-6.

80. Bravo C. Absceso hepático. Estudio de 122 casos comprobados. I. Presentación de 100 casos en adultos. Antioquia Med 1964; 14:681-722.

81. Bravo C. Absceso hepático. Estudio de 122 casos comprobados. II. Presentación de 22 casos en niños. Antioquia Med 1965; 15:427-48.

82. Mondragón-Sanchez R, Cortés-Espinoza T, Alonzo-Fierro Y, Labra-Villalobos MI, Bernal Maldonado R. Amebic liver abscess “a 5 year Mexican experience with a multimodality approach”. Hepatogastroenterology. 1995 Sep-Oct;42(5):473-7.

83. Johnson JL, Baird JS, Hulbert TV, Opas LM. Amebic liver abscess in infancy: case report and review. Clin Infect Dis. 1994 Oct;19(4):765-7.

84. Restrepo MI, Restrepo Z, Elsa Villareal CL, Aguirre A, Restrepo M. Diagnostic tests for amoebic liver abscess: comparison of enzyme-linked immunosorbent assay (ELISA) and counterimmunoelectrophoresis (CIE). Rev Soc Bras Med Trop. 1996 Jan-Feb;29(1):27-32.

85. Stark D, Fotedar R, van Hal S, Beebe N, Marriott D, Ellis JT, et al. Prevalence of enteric protozoa in human immunodeficiency virus (HIV)-positive and HIV-negative men who have sex with men from Sydney, Australia. Am J Trop Med Hyg. 2007 Mar;76(3):549-52.

86. Mokhtari M, Kumar PV. Amebic liver abscess: fine needle aspiration diagnosis. Acta Cytol. 2014;58(3):225-8.

87. Vallois D, Epelboin L, Touafek F, Magne D, Thellier M, Bricaire F, et al. Amebic liver abscess diagnosed by polymerase chain reaction in 14 returning travelers. Am J Trop Med Hyg. 2012 Dec;87(6):1041-5.

88. Jaiswal V, Ghoshal U, Baijal SS, Mittal B, Dhole TN, Ghoshal UC. Evaluation of antigen detection and polymerase chain reaction for diagnosis of amoebic liver abscess in patients on anti-amoebic treatment. BMC Res Notes. 2012 Aug 7;5:416.

89. Chen HL, Bair MJ, Lin IT, Wu CH, Lee YK. Clinical manifestation and risk factors of amebic liver abscess in Southeast Taiwan compared with other regions of Taiwan. Am J Trop Med Hyg 2013 Dec 4;89(6):1214-8.

90. Acuna-Soto R, Maguire JH, Wirth DF. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol. 2000 May;95(5):1277-83.

91. Stanley SL Jr. Amoebiasis. Lancet. 2003 Mar 22;361(9362):1025-34.

92. Quaderi MA, Rahman MS, Rahman A, Islam N. Amoebic liver abscess and clinical experiences with tinidazole in Bangladesh. J Trop Med Hyg. 1978 Jan;81(1):16-9.

93. Bhatia S, Karnad DR, Oak JL. Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian J Gastroenterol. 1998 Apr;17(2):53-4.

94. Jain NK, Madan A, Sharma TN, Sharma DK, Mandhana RG. Hepatopulmonary amoebiasis. Efficacy of various treatment regimens containing dehydroemetine and/or metronidazole. J Assoc Physicians India. 1990 Apr;38(4):269-71.

95. Echegoyen-Carmona R, Medina-Morales F, Chavarría-Garcés J, Flórez-Vergara H. Complicaciones pleuropulmonares del absceso hepático amibiano. Acta Méd 1996;31:23-4.

96. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. Amebiasis. N Engl J Med. 2003 Apr 17;348(16):1565-73.

97. Bonner M, Amard V, Bar-Pinatel C, Charpentier F, Chatard JM, Desmuyck Y, et al. Detection of the amoeba Entamoeba gingivalis in periodontal pockets. Parasite 2014;21:30. Doi: 10.1051/parasite/2014029.